Invention Grant
- Patent Title: Use of interleukin-22 in treating viral hepatitis
- Patent Title (中): 使用白介素22治疗病毒性肝炎
-
Application No.: US13819717Application Date: 2011-08-30
-
Publication No.: US08945528B2Publication Date: 2015-02-03
- Inventor: Xiaoqiang Yan , Zhihua Huang , Hongzhou Yang , Yuliang Huang
- Applicant: Xiaoqiang Yan , Zhihua Huang , Hongzhou Yang , Yuliang Huang
- Applicant Address: CN
- Assignee: Generon (Shanghai) Corporation Ltd.
- Current Assignee: Generon (Shanghai) Corporation Ltd.
- Current Assignee Address: CN
- Agency: Morrison & Foerster LLP
- Priority: CN201010268320 20100831
- International Application: PCT/CN2011/079124 WO 20110830
- International Announcement: WO2012/028089 WO 20120308
- Main IPC: A61K38/20
- IPC: A61K38/20 ; C07K19/00 ; C07K14/54 ; C12P21/04
Abstract:
This invention relates to a use of IL-22 in the treatment of viral hepatitis. As illustrated in the examples of this invention, IL-22 can significantly reduce liver damage caused by hepatitis virus, and can significantly reduce the increase of transaminase ALT/AST induced by hepatitis virus. In addition, the IL-22 dimer of this invention can effectively treat viral hepatitis.
Public/Granted literature
- US20130171100A1 USE OF INTERLEUKIN-22 IN TREATING VIRAL HEPATITIS Public/Granted day:2013-07-04
Information query
IPC分类:
